Hocoma and Saebo Partner to Deliver Compact, Affordable Rehabilitation Solution for Upper Extremities

ZURICH & CHARLOTTE, N.C.–(BUSINESS WIRE)–Hocoma and Saebo today announced a partnership to improve the training
possibilities for patients with moderate to mild impairments of the
upper extremities. Together, the SaeboMas Mini and the ArmeoSenso
deliver an easy-to-use, compact solution at an affordable price.

“Saebo is committed to helping patients around the globe achieve a new
level of independence,” said Henry Hoffman, co-founder of Saebo.
“Together with an industry leader such as Hocoma, we believe we can
maximize the potential of our affordable and evidence-based solutions.”

“We are very excited to be working with Saebo,” said Hocoma CEO and
co-founder Dr. Gery Colombo. “Neurological disorders afflict thousands
of people each year and by teaming up with another leading player in the
industry, we expect to be able to help even more patients recover faster
and with better long-term outcomes than conventional rehabilitation
therapy can offer.”

In the future, Saebo and Hocoma plan to deepen their partnership.
Further solutions are expected to be optimized so that they complement
each other as perfectly as the SaeboMas Mini and the ArmeoSenso. Dr.
Gery Colombo added: “Our ultimate goal is to provide all patients with a
compact, affordable rehabilitation solution – regardless of the specific
body parts affected by neurological damage.”

The new partnership can be experienced live at Rehabweek in London from
July 17-21.

About Hocoma

A successful therapy begins in patients’ heads. In the firm belief that
– step by step – they can reach their goals and regain quality of life.

This is what we work for at the Swiss medtech company Hocoma. With
technologies and ideas that look at functional movement therapy from a
completely different angle. Because they enable independent exercises
and create maximum motivation. Because they challenge people to take
courage and support their hopes with personal achievements.

We are committed to creating the ideal therapy. Our awarded robotic and
sensor-based devices offer solutions for intensive gait therapy
(Lokomat®, Andago®), functional therapy of the upper extremities
(Armeo®), robotic mobilization and functional electrical stimulation in
early rehabilitation (Erigo®) as well as functional movement therapy
within low back pain treatment (Valedo® Therapy Concept) at home and at
the clinic. They are the result of intensive research, consistent
development and continuous exchange with patients, therapists and
partners in research and science.

Those who see to break new grounds need to stay open to exceptional
ideas. They have the potential of being exceptionally effective. This
guiding principle by Hocoma founder and CEO Dr. Gery Colombo has
accompanied us since our start in 2000 and is still lived and
implemented by our dedicated employees around the world. At the
headquarters in Volketswil near Zurich (Switzerland) and the
subsidiaries in the USA, Singapore and Slovenia they achieved a turnover
of 30 million CHF in 2016.

About Saebo

Saebo, Inc. is a medical device company primarily engaged in the
discovery, development and commercialization of affordable and novel
clinical solutions designed to improve mobility and function in
individuals suffering from neurological and orthopedic conditions. With
a vast network of Saebo-trained clinicians spanning six continents,
Saebo has helped over 250,000 clients around the globe achieve a new
level of independence.

For more information about Saebo, please visit: www.saebo.com.

Product Disclaimer

All Hocoma products are medical devices and must be used in strict
adherence to the User Manual; failure to do so may result in serious
personal injury. It is strongly recommended that you regularly consult
Hocoma’s website (www.hocoma.com/legalnotes)
for the latest available information. Please contact Hocoma in case of
any questions.

Use only under the supervision of qualified medical personnel. However,
certain Hocoma products are marketed for home use and must be strictly
used according to the recommendations of your medical care provider who
is knowledgeable about your specific needs. Consult the User Manual and
Hocoma’s website (www.hocoma.com/legalnotes)
for appropriate product designation. Failure to obtain and follow the
recommendations of your medical care provider may result in serious
personal injury.

This information provides details about medical products which may not
be available in all countries and may not have received approval or
market clearance by all governmental regulatory bodies throughout the
world. Nothing herein should be construed as a solicitation or promotion
of any product or of an indication of any specific use for any product
which is not authorized by the laws and regulations of the country where
the reader of this information resides.

Contacts

Hocoma AG
Mike Fuhrmann, +41 43 444 23 65
Chief Creative
Officer
[email protected]
Fax:
+41 43 444 22 01
www.hocoma.com